Veradigm Inc. (NASDAQ:MDRX – Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $9.50, but opened at $9.25. Veradigm shares last traded at $9.50, with a volume of 63,337 shares trading hands.
Analyst Ratings Changes
Separately, StockNews.com initiated coverage on Veradigm in a report on Thursday. They set a “hold” rating on the stock. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Veradigm has an average rating of “Hold” and an average price target of $11.75.
View Our Latest Analysis on MDRX
Veradigm Stock Down 1.6 %
Institutional Investors Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new position in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Pros And Cons Of Monthly Dividend Stocks
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- Retail Stocks Investing, Explained
- Time to Board Carnival Cruise Lines’ Stock Price Rally
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.